Joshua M. Sharfstein, MD; Scott J. Becker, MS; Michelle M. Mello, JD, PhD
free access
has multimedia
has audio
JAMA. 2020;323(15):1437-1438. doi:10.1001/jama.2020.3864
This Viewpoint explains the technical and regulatory challenges that hampered diagnostic testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the early spread of infection in the US and considers the unintended consequences of making testing more widely available, including false-negative results and overtesting.
-
Video:
Coronavirus Testing
-
Podcast:
Coronavirus Testing 鈥� March 16 Q&A with the CDC鈥檚 Jay Butler, MD
-
Podcast:
Coronavirus Disease 2019 (COVID-19) Update: PCR Testing and Shortages
James G. Adams, MD; Ron M. Walls, MD
free access
has audio
JAMA. 2020;323(15):1439-1440. doi:10.1001/jama.2020.3972
This Viewpoint discusses the importance of protecting health care workers caring for patients with coronavirus disease 2019 (COVID-19) and measures that can be taken in and out of the hospital to prevent their and their families鈥� exposure to SARS-CoV-2.
-
Podcast:
The Effect of the COVID-19 Pandemic on Clinic Operations
-
Podcast:
COVID-19 in Seattle: Clinical Features and Managing the Outbreak
-
Podcast:
COVID-19: Applying What Was Learned by SARS to a Modern Pandemic
-
Editorial
Health Care Heroes of the COVID-19 Pandemic
Howard Bauchner, MD; Thomas J. Easley; on behalf of the entire editorial and publishing staff of JAMA and the 糖心vlog
JAMA
Stephen M. Parodi, MD; Vincent X. Liu, MD, MSc
free access
has multimedia
has audio
JAMA. 2020;323(15):1441-1442. doi:10.1001/jama.2020.3882
This Viewpoint discusses Kaiser Permanente in Northern California鈥檚 transition from a containment strategy for coronavirus disease 2019 (COVID-19)鈥攊solation or quarantine of exposed or infected patients鈥攖o a mitigation strategy comprising elements such as droplet and airborne precautions, telemedicine, staffing protocol revisions, and equipment allocation planning.
-
Video:
Coronavirus (COVID-19) Mitigation: Preparing Hospitals and Health Systems
-
Video:
Coronavirus Update with Anthony Fauci, MD 鈥� March 18, 2020
-
Podcast:
COVID-19 in Seattle: Clinical Features and Managing the Outbreak
-
Podcast:
Coronavirus Disease 2019 (COVID-19) Mitigation: Preparing Hospitals and Health Systems
Madison K. Kilbride, PhD; Angela R. Bradbury, MD
has audio
JAMA. 2020;323(15):1443-1444. doi:10.1001/jama.2019.22504
This Viewpoint summarizes current shortcomings in direct-to-consumer genetic tests, which often lack clinical utility for consumers, and explains how tests that encompass entire genes and include only genes with well-established risk estimates and medical management guidelines could provide more valuable insight into their disease risk.
-
Podcast:
The Need to Improve the Clinical Utility of Direct-to-Consumer Genetic Tests: Either Too Narrow or Too Broad
W. Gregory Feero, MD, PhD; Catherine A. Wicklund, MS, CGC
JAMA. 2020;323(15):1445-1446. doi:10.1001/jama.2020.3525
This Viewpoint discusses gaps between the growth of direct-to-consumer genomic testing and knowledge about how best to use the information, highlighting the absence of diversity in genetic databases, the scarcity of accompanying genetic counseling, and data security and privacy concerns.